Literature DB >> 9012417

Genetic effects on variation in red-blood-cell folate in adults: implications for the familial aggregation of neural tube defects.

L E Mitchell1, D L Duffy, P Duffy, G Bellingham, N G Martin.   

Abstract

Recent studies have implicated folic acid as an important determinant of normal human growth, development, and function. Insufficient folate levels appear to be a risk factor for neural tube defects (NTD), as well as for several chronic diseases of adulthood. However, relatively little is known about the factors that influence folate status in the general population. To estimate the relative contribution of genetic and nongenetic factors to variation in folate, we have evaluated red blood cell (RBC) folate levels in 440 pairs of MZ twins and in 331 pairs of DZ twins. The data were best described by a model in which 46% of the variance in RBC folate was attributable to additive genetic effects, 16% of the variance was due to measured phenotypic covariates, and 38% of the variance was due to random environmental effects. Moreover, the correlations for RBC folate in MZ co-twins (r = .46) and in repeat measures from the same individual (r = .51) were very similar, indicating that virtually all repeatable variation in RBC folate is attributable to genetic factors. On the basis of these results, it would seem reasonable to initiate a search for the specific genes that influence RBC folate levels in the general population. Such genes ultimately may be used to identify individuals at increased risk for NTD and other folate-related diseases.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9012417      PMCID: PMC1712395     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  15 in total

1.  Pathways to hysterectomy: insights from longitudinal twin research.

Authors:  S A Treloar; N G Martin; L Dennerstein; B Raphael; A C Heath
Journal:  Am J Obstet Gynecol       Date:  1992-07       Impact factor: 8.661

2.  Modelling the influence of risk factors on familial aggregation of disease.

Authors:  O O Aalen
Journal:  Biometrics       Date:  1991-09       Impact factor: 2.571

Review 3.  Clinical chemistry of folic acid.

Authors:  R E Davis
Journal:  Adv Clin Chem       Date:  1986       Impact factor: 5.394

4.  Programs for Pedigree Analysis: MENDEL, FISHER, and dGENE.

Authors:  K Lange; D Weeks; M Boehnke
Journal:  Genet Epidemiol       Date:  1988       Impact factor: 2.135

Review 5.  Folic acid and the prevention of neural tube defects.

Authors:  N Wald
Journal:  Ann N Y Acad Sci       Date:  1993-03-15       Impact factor: 5.691

6.  Folates and the fetus.

Authors:  I Leck
Journal:  Lancet       Date:  1977-05-21       Impact factor: 79.321

7.  Periconceptional multivitamin use in relation to the risk of congenital urinary tract anomalies.

Authors:  D K Li; J R Daling; B A Mueller; D E Hickok; A G Fantel; N S Weiss
Journal:  Epidemiology       Date:  1995-05       Impact factor: 4.822

8.  Familial aggregation of a disease consequent upon correlation between relatives in a risk factor measured on a continuous scale.

Authors:  J L Hopper; J B Carlin
Journal:  Am J Epidemiol       Date:  1992-11-01       Impact factor: 4.897

9.  Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation.

Authors:  A E Czeizel; I Dudás
Journal:  N Engl J Med       Date:  1992-12-24       Impact factor: 91.245

10.  A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes.

Authors:  C J Boushey; S A Beresford; G S Omenn; A G Motulsky
Journal:  JAMA       Date:  1995-10-04       Impact factor: 56.272

View more
  2 in total

1.  Dizygotic twins with myelomeningocele.

Authors:  Ghanshyam Das; Anju Aggarwal; M M A Faridi
Journal:  Indian J Pediatr       Date:  2003-03       Impact factor: 1.967

2.  Methionine synthase and neural tube defects.

Authors:  K Morrison; Y H Edwards; S A Lynch; J Burn; F Hol; E Mariman
Journal:  J Med Genet       Date:  1997-11       Impact factor: 6.318

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.